鶹Ƶ

skip to main content

Product liability litigation regularly involves the highest stakes in cases of extreme complexity. Faced with such franchise-threatening matters, the world’s leading corporations trust 鶹Ƶ, Weiss to lead them to victory. Our superior ability to establish a winning, long-term strategy, our unique skill at breaking down and presenting complicated material, and our vaunted trial prowess make us counsel of choice in many of the most important product liability lawsuits.

Publications

Kim Branscome, Jonathan Tam and Matthew Steinberg Publish Article on MDLs’ “Field of Dreams” Problem in Bloomberg Law

Litigation partners Kim Branscome and Jonathan Tam and associate Matthew Steinberg co-wrote an article in Bloomberg Law discussing recent reform efforts to deal with a judicial phenomenon in multidistrict litigation.

» more

Firm News

Leading Product Liability and Mass Torts Trial Lawyer to Join 鶹Ƶ, Weiss in Los Angeles

Nationally renowned trial lawyer and litigation strategist Kimberly Branscome has joined the firm as a partner in Los Angeles.

» more

Events

Erin Morgan Discusses Risk of Mass Tort Litigation Over Social Media Addiction

Litigation partner Erin Morgan participated in a panel on March 22, “Applying the MDL Frameworks to Social Media,” as a part of the Federal Communications Law Journal Symposium hosted by George Washington University Law School.

» more

Publications

Jonathan Tam Discusses His Product Liability Career Path on HSU Untied Podcast

Litigation partner Jonathan Tam was the featured guest on the May 20 episode of the HSU untied podcast hosted by Richard Hsu.

» more

Events

Kim Branscome to Participate in Trial Lawyers of Mass Torts Conference

Litigation partner Kim Branscome will speak on two panels at the Trial Lawyers of Mass Torts Conference in Park City, Utah.

» more

Client News

JM Eagle Prevails in High-Stakes FCA Case

鶹Ƶ, Weiss prevailed in a high-stakes False Claims Act damages lawsuit against our client, JM Eagle, when a judge issued a judgment as a matter of law and dismissed the case.

» more

Client News

AbbVie Achieves Complete Defense Verdict

鶹Ƶ, Weiss achieved a complete defense verdict for AbbVie Inc. in a products liability suit relating to AbbVie’s testosterone replacement therapy, concluding a two week trial in state court in Cook County, Illinois.

» more

Client News

Pfizer Achieves Trial Victory in Second Zoloft Birth Defects Case

鶹Ƶ, Weiss client Pfizer achieved a major victory in the second Zoloft birth defects case to go to trial in the U.S. At the conclusion of an eight-day trial, a Philadelphia jury returned a complete defense verdict and concluded that Pfizer's warnings about the risks of Zoloft were adequate.

» more

Client News

Pfizer Wins First U.S. Trial Over Zoloft Birth-Defect Risk

As reported in BloombergReuters and other media outlets, 鶹Ƶ, Weiss client Pfizer achieved a major victory in the first Zoloft birth defects case to go to trial in the U.S. At the conclusion of a seven-day trial, a St. Louis jury returned a complete defense verdict in under two hours. The jury rejected the plaintiff's allegations that a mother's use of Zoloft in the first trimester of her pregnancy caused her child's cardiac birth defect.

» more

Client News

Pfizer Wins Dismissal of Shareholder Class Action Suit

As reported by Thomson Reuters and Law.com, 鶹Ƶ, Weiss client Pfizer Inc. achieved a major victory when a federal court granted the company's motion for summary judgment in In Re Pfizer Inc. Securities Litigation, a securities class action filed in the United States District Court for the Southern District of New York involving decade-old disclosures related to Celebrex and Bextra.

» more

© 2024 鶹Ƶ, Wharton & Garrison LLP

Privacy Policy